BIOMAT Database Logo BIOMAT Database Logo

Genetic variants in Lp(a) lipoprotein and coronary disease. 2010

Beate R Jaeger, and Carlos A Labarrere

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001781 Blood Component Removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor. Apheresis,Pheresis,Aphereses,Blood Component Removals,Phereses,Removal, Blood Component
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

Beate R Jaeger, and Carlos A Labarrere
Genetic variants in Lp(a) lipoprotein and coronary disease.
March 2010, The New England journal of medicine,
Beate R Jaeger, and Carlos A Labarrere
Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
December 2009, The New England journal of medicine,
Beate R Jaeger, and Carlos A Labarrere
Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
March 2020, BMC medical genetics,
Beate R Jaeger, and Carlos A Labarrere
Lipoprotein Lp(a) excess and coronary heart disease.
June 1997, Archives of internal medicine,
Beate R Jaeger, and Carlos A Labarrere
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
July 2005, The New England journal of medicine,
Beate R Jaeger, and Carlos A Labarrere
Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease.
January 1974, Clinical genetics,
Beate R Jaeger, and Carlos A Labarrere
Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease.
May 1991, The American journal of cardiology,
Beate R Jaeger, and Carlos A Labarrere
Lp(a) lipoprotein and HLA-DR genotype in early coronary artery disease.
April 1993, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
Beate R Jaeger, and Carlos A Labarrere
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).
January 2020, Journal of clinical lipidology,
Beate R Jaeger, and Carlos A Labarrere
Lipoprotein Lp(a) and atherothrombotic disease.
January 2000, Archives of medical research,
Copied contents to your clipboard!